Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Eric Karran
Based on 16 articles published since 2010
(Why 16 articles?)
||||
Expertise Level
The expertise of Eric Karran ranks in the
  • Top 0.091%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 16 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Karran, Eric   ·   Karran, E
Work Locations
Details
Most likely:    Katholieke Universiteit Leuven      
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
2016
  • VIB Center for the Biology of Disease, VIB-Leuven, 3000 Leuven, Belgium; Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK. Electronic address: · Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK; Alzheimer Research UK, Cambridge, CB21 6AD, UK. · Pubmed 26871627
2012
  • Center for Human Genetics and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven, Leuven, Belgium. · Pubmed 22286176
Probable:    University College London      
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
2016
  • Alzheimer's Research UK Research, Cambridge, Cambridgeshire, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Center for Human Genetics, Universitaire ziekenhuizen and LIND, KU Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · Pubmed 27255958
  • VIB Center for the Biology of Disease, VIB-Leuven, 3000 Leuven, Belgium; Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK. Electronic address: · Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK; Alzheimer Research UK, Cambridge, CB21 6AD, UK. · Pubmed 26871627
2014
  • From Reta Lila Weston Laboratories and the Department of Molecular Neuroscience, University College London, London (E.K., J.H.), and Alzheimer's Research UK, Cambridge (E.K.) - both in the United Kingdom. · Pubmed 24450897
  • Alzheimer's Research UK, Cambridge; Reta Lila Weston Laboratories, London; Department of Molecular Neuroscience, University College London, London, United Kingdom. · Pubmed 24853080
Probable:    AbbVie      
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 16 total) written by Eric Karran about Alzheimer Disease:

  • Precision pharmacology for Alzheimer's disease. 2018
  • The amyloid cascade hypothesis: are we poised for success or failure? 2016
  • The Cellular Phase of Alzheimer's Disease. 2016
  • Recent trial shows that solanezumab has disease modifying effects. 2015
  • Eric Karran. 2015
  • Antiamyloid therapy for Alzheimer's disease--are we on the right road? 2014
  • A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. 2014
  • An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease. 2013
  • Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. 2013
  • Current status of vaccination therapies in Alzheimer's disease. 2012
Show List of Full Article Records
Google Searches

Learn more about Eric Karran using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Katholieke Universiteit Leuven
University College London
AbbVie
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Katholieke Universiteit Leuven
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
2016
  • VIB Center for the Biology of Disease, VIB-Leuven, 3000 Leuven, Belgium; Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK. Electronic address: · Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK; Alzheimer Research UK, Cambridge, CB21 6AD, UK. · Pubmed 26871627
2012
  • Center for Human Genetics and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven, Leuven, Belgium. · Pubmed 22286176
University College London
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
2016
  • Alzheimer's Research UK Research, Cambridge, Cambridgeshire, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Center for Human Genetics, Universitaire ziekenhuizen and LIND, KU Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · Pubmed 27255958
  • VIB Center for the Biology of Disease, VIB-Leuven, 3000 Leuven, Belgium; Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK. Electronic address: · Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK; Alzheimer Research UK, Cambridge, CB21 6AD, UK. · Pubmed 26871627
2014
  • From Reta Lila Weston Laboratories and the Department of Molecular Neuroscience, University College London, London (E.K., J.H.), and Alzheimer's Research UK, Cambridge (E.K.) - both in the United Kingdom. · Pubmed 24450897
  • Alzheimer's Research UK, Cambridge; Reta Lila Weston Laboratories, London; Department of Molecular Neuroscience, University College London, London, United Kingdom. · Pubmed 24853080
AbbVie
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
Vlaams Instituut voor Biotechnologie
2016
  • Alzheimer's Research UK Research, Cambridge, Cambridgeshire, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Center for Human Genetics, Universitaire ziekenhuizen and LIND, KU Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · Pubmed 27255958
2012
2011
  • Department of Molecular and Developmental Genetics, VIB, 3000 Leuven, Belgium. · Pubmed 21209097
National Hospital for Neurology and Neurosurgery
2016
  • VIB Center for the Biology of Disease, VIB-Leuven, 3000 Leuven, Belgium; Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK. Electronic address: · Center for Human Genetics, Universitaire Ziekenhuizen and LIND, KU Leuven, 3000 Leuven, Belgium; Institute of Neurology, University College London, Queen Square, WC1N 3BG London, UK; Alzheimer Research UK, Cambridge, CB21 6AD, UK. · Pubmed 26871627
Miscellaneous institutions in Cambridge, UK
2016
  • Alzheimer's Research UK Research, Cambridge, Cambridgeshire, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · VIB Center for the Biology of Disease, VIB-Leuven, Leuven, Belgium. · Center for Human Genetics, Universitaire ziekenhuizen and LIND, KU Leuven, Leuven, Belgium. · Institute of Neurology, University College London, London, UK. · Pubmed 27255958
Unspecified
2015
Johnson and Johnson
2011
  • Janssen Research and Development, Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium. eric.karran@gmail. com · Pubmed 21852788
2011
  • Neuroscience Department, Johnson & Johnson Pharmaceutical Research and Development, Janssen Pharmaceutica, Beerse, Belgium. · Pubmed 21232036
4 Other Locations Show
Yearly article counts 00102222430
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.